Proteovant Therapeutics

Proteovant Therapeutics is leveraging targeted protein degradation to discover and develop transformative medicines for disease treatment. Proteovant Therapeutics integrates its foundational degrader portfolio, extensive in-house drug discovery expertise, and VantAI's proprietary "protein contact-first" deep learning platform to advance novel protein degraders across a range of therapeutic areas.